WallStreetZenWallStreetZen

NASDAQ: CLNN
Clene Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CLNN

Based on 2 analysts offering 12 month price targets for Clene Inc

Min Forecast
$23.00+331.92%
Avg Forecast
$35.50+566.67%
Max Forecast
$48.00+801.41%

Should I buy or sell CLNN stock?

Based on 2 analysts offering ratings for Clene Inc.

Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CLNN's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates CLNN as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their CLNN stock forecasts and price targets.

CLNN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-13
lockedlocked$00.00+00.00%2026-03-12

1 of 1

Forecast return on equity

Is CLNN forecast to generate an efficient return?

Company
-398.14%
Industry
68.21%
Market
181.01%
CLNN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CLNN forecast to generate an efficient return on assets?

Company
386.3%
Industry
31.86%
CLNN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CLNN earnings per share forecast

What is CLNN's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$2.12
Avg 2 year Forecast
-$0.90
Avg 3 year Forecast
$0.52

CLNN revenue forecast

What is CLNN's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$224.4k+12.2%
Avg 2 year Forecast
$46.1M+22,974%
Avg 3 year Forecast
$169.1M+84,440%
CLNN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CLNN revenue growth forecast

How is CLNN forecast to perform vs Biotechnology companies and vs the US market?

Company
821%
Industry
35.63%
Market
13.32%
CLNN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CLNN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CLNN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CLNN$5.33$35.50+566.67%Strong Buy
CYPH$0.71N/AN/A
IMA$5.69$16.00+181.20%Hold
EDSA$7.35$5.00-31.97%Buy
ACRV$1.66$13.50+713.25%Strong Buy
View Top Biotech Stocks

Clene Stock Forecast FAQ

Is Clene Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CLNN) stock is to Strong Buy CLNN stock.

Out of 2 analysts, 2 (100%) are recommending CLNN as a Strong Buy, 0 (0%) are recommending CLNN as a Buy, 0 (0%) are recommending CLNN as a Hold, 0 (0%) are recommending CLNN as a Sell, and 0 (0%) are recommending CLNN as a Strong Sell.

If you're new to stock investing, here's how to buy Clene stock.

What is CLNN's earnings growth forecast for 2026-2028?

(NASDAQ: CLNN) Clene's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.93%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.08%.

Clene's earnings in 2026 is -$26,173,000.On average, 8 Wall Street analysts forecast CLNN's earnings for 2026 to be -$24,988,856, with the lowest CLNN earnings forecast at -$35,551,642, and the highest CLNN earnings forecast at -$8,780,728. On average, 8 Wall Street analysts forecast CLNN's earnings for 2027 to be -$10,572,208, with the lowest CLNN earnings forecast at -$26,202,022, and the highest CLNN earnings forecast at $6,307,283.

In 2028, CLNN is forecast to generate $6,127,075 in earnings, with the lowest earnings forecast at -$6,579,362 and the highest earnings forecast at $19,663,884.

What is CLNN's revenue growth forecast for 2026-2028?

(NASDAQ: CLNN) Clene's forecast annual revenue growth rate of 821% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.63%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.32%.

Clene's revenue in 2026 is $200,000.On average, 7 Wall Street analysts forecast CLNN's revenue for 2026 to be $2,643,052, with the lowest CLNN revenue forecast at $692,564, and the highest CLNN revenue forecast at $4,946,889. On average, 7 Wall Street analysts forecast CLNN's revenue for 2027 to be $543,545,311, with the lowest CLNN revenue forecast at $2,308,548, and the highest CLNN revenue forecast at $1,586,773,519.

In 2028, CLNN is forecast to generate $1,991,476,148 in revenue, with the lowest revenue forecast at $263,174,492 and the highest revenue forecast at $3,277,313,923.

What is CLNN's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: CLNN) forecast ROA is 386.3%, which is higher than the forecast US Biotechnology industry average of 31.86%.

What is CLNN's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CLNN price target, the average CLNN price target is $35.50, with the highest CLNN stock price forecast at $48.00 and the lowest CLNN stock price forecast at $23.00.

On average, Wall Street analysts predict that Clene's share price could reach $35.50 by Mar 13, 2027. The average Clene stock price prediction forecasts a potential upside of 566.67% from the current CLNN share price of $5.33.

What is CLNN's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: CLNN) Clene's current Earnings Per Share (EPS) is -$2.65. On average, analysts forecast that CLNN's EPS will be -$2.12 for 2026, with the lowest EPS forecast at -$3.02, and the highest EPS forecast at -$0.75. On average, analysts forecast that CLNN's EPS will be -$0.90 for 2027, with the lowest EPS forecast at -$2.22, and the highest EPS forecast at $0.54. In 2028, CLNN's EPS is forecast to hit $0.52 (min: -$0.56, max: $1.67).

What is CLNN's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: CLNN) forecast ROE is -398.14%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.